StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories u.S. FDA 510(k) Device Clearances — Abbott

U.S. FDA openFDA Device Clearances, Approvals & Recalls API

QuarterlyAnnualMonthly
Latest, Q3 2026
6
Period ended Sep 30, 2026
Change on a year earlier
-33.3%
9 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. FDA 510(k) Device Clearances — AbbottYear on yearSource
Q3 2026Sep 30, 20266-33.3%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2026Jun 30, 202680.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2026Mar 31, 20262-71.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2025Dec 31, 202550.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2025Sep 30, 20259+125.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2025Jun 30, 20258+60.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2025Mar 31, 20257+250.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2024Dec 31, 202450.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2024Sep 30, 20244-69.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2024Jun 30, 20245-44.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2024Mar 31, 20242-60.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2023Dec 31, 20235-16.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2023Sep 30, 202313+333.3%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2023Jun 30, 20239-35.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2023Mar 31, 202350.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2022Dec 31, 20226+50.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗

Breakdown

What makes up u.s. fda 510(k) device clearances — abbott

Cite this data

StockData. (2026). Abbott Laboratories U.S. FDA 510(k) Device Clearances — Abbott, quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-510k-co

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.